Packaging Size	0.5 ml
Packaging Type	Injection
Brand	Mounjaro
Manufacturer	ELI LILLY AND COMPANY INDIA PVT LTD
Prescription	Yes
Usage / Application	Management of type 2 diabetes mellitus in adults to improve glycemic control as an adjunct to diet a
Storage Conditions	Cold Chain
Strength	5 mg

Introduction to Mounjaro 2.5mg Injection

Mounjaro 2.5mg Injection, an innovative medication, contains Tirzepatide as its active constituent. It belongs to the pharmacological class of GLP-1 and GIP receptor agonists and is used primarily to manage blood sugar levels in adults with type 2 diabetes. This injectable medication helps improve glycemic control by mimicking the actions of natural incretin hormones. It enhances insulin secretion while reducing the release of glucagon, helping lower blood sugar after meals.

Apart from glycemic control, Mounjaro 2.5mg Injection shows promise in promoting weight loss, making it beneficial for individuals with obesity or those looking to improve their metabolic health. It is typically prescribed as an adjunct to diet and exercise in patients who have not achieved desired control with oral antidiabetic medications. However, this medication is contraindicated in individuals with a history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2. Caution is advised in patients with kidney or gastrointestinal disorders.

Healthcare providers should evaluate the risk factors before prescribing Mounjaro 2.5mg Injection. Safety considerations include monitoring for thyroid tumors, pancreatitis, and severe hypoglycemia, especially when used alongside insulin or other antidiabetic agents.

Uses of Mounjaro 2.5mg Injection

FDA-approved uses of Mounjaro 2.5mg Injection include:

Management of type 2 diabetes mellitus in adults to improve glycemic control as an adjunct to diet and exercise.
Support in weight management for adults with obesity or overweight conditions, particularly those with related comorbidities.

Therapeutic Effects of Mounjaro 2.5mg Injection

Mounjaro 2.5mg Injection works by mimicking the actions of two key incretin hormones: GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide). These hormones play a vital role in regulating blood sugar by:

Stimulating the pancreas to release insulin after food intake.
Suppressing the release of glucagon from the liver, reducing glucose production.
Slowing gastric emptying, which prolongs the feeling of fullness and helps reduce calorie intake.

This dual mechanism not only improves blood sugar levels but also contributes to significant weight reduction over time.

Interaction of Mounjaro 2.5mg Injection with other drugs

Certain medications may interact with Mounjaro 2.5mg Injection, potentially leading to adverse effects. It is important to exercise caution when combining this medication with:

Insulin or Sulfonylureas: Increased risk of severe hypoglycemia. Consider dose adjustment.
Oral Contraceptives: May delay gastric emptying, reducing the effectiveness of birth control pills.
Warfarin: May alter anticoagulant effects. Regular monitoring is required.
Digoxin: Reduced absorption and possible alterations in therapeutic response.

Contraindications:

Do not use in patients with a personal or family history of medullary thyroid carcinoma.
Avoid in individuals diagnosed with multiple endocrine neoplasia syndrome type 2.
Contraindicated in patients with severe gastrointestinal disease or pancreatitis history.

Always inform your healthcare provider about any other medications or supplements before starting Mounjaro 2.5mg Injection to prevent harmful interactions.

Additional Information: